---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-22-013253"
form_type: "8-K"
ticker: "LIXT"
cik: "0001335105"
company_name: "LIXTE BIOTECHNOLOGY HOLDINGS, INC."
filed_at: "2022-05-13T23:59:59+00:00"
generated_at: "2026-06-25T16:29:29.075287+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Director Philip Palmedo will not stand for reelection at Lixte's upcoming Annual Meeting

## Summary
- Philip Palmedo informed Lixte on May 9, 2022 that he will not seek reelection at the next Annual Meeting.
- He will continue serving as a director until the Annual Meeting date.
- Dr. Palmedo had served as a director since June 30, 2006, over 15 years.
- No reason for the decision was disclosed in the filing.

## SEC filing metadata
- accession: 0001493152-22-013253
- form_type: 8-K
- ticker: LIXT
- cik: 0001335105
- company_name: LIXTE BIOTECHNOLOGY HOLDINGS, INC.
- filed_at: 2022-05-13T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1335105/000149315222013253/0001493152-22-013253-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1335105/000149315222013253/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-22-013253
- JSON: https://secwatch.observer/filing/0001493152-22-013253.json
- Plain text: https://secwatch.observer/filing/0001493152-22-013253.txt

## Key facts
- Executive change
  Philip Palmedo departed as Director at LIXTE BIOTECHNOLOGY HOLDINGS, INC..
  - Action: did not intend to stand for reelection
  - Role: Director
  source text: On May 9, 2022, Philip Palmedo informed the Company that he did not intend to stand for reelection at the next Annual Meeting of Stockholders of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1335105/000149315222013253/0001493152-22-013253-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.